Add the possibility of reducing cravings and anxiety in heroin addicts to the growing list of potential CBD uses.
Researchers at Mount Sinai Hospital in New York announced Tuesday that results of a small study found a promising, and unexpected, new use of CBD: a reduction of cue-induced cravings and anxiety in individuals with a history of heroin abuse, suggesting a potential role for it in helping to break heroin drug addiction.
The results of the study are published in the American Journal of Psychiatry.
“To address the critical need for new treatment options for the millions of people and families who are being devastated by this epidemic, we initiated a study to assess the potential of a nonintoxicating cannabinoid on craving and anxiety in heroin-addicted individuals,” said lead study author Yasmin Hurd, director of the Addiction Institute at Mount Sinai in a statement
Sativa Investments (NEX:SATI) is the UK’s first medicinal cannabis investment vehicle. After investing in two North American businesses, it is now progressing a UK seed to consumer investment strategy with 100% ownership of businesses involved in the production, testing and compliance, research & development including pharmacology, commercialisation and sales & marketing of medicinal cannabis and cannabidiol products. Two UK businesses, George Botanicals and PhytoVista Laboratories, are already fully operational.